NCT06215859

Study of MR-107A-02 for the Treatment of Acute Postoperative Pain Following Herniorrhaphy

Multi-Center, Randomized, Double-Blind, Placebo (Double-Dummy) and Active-Controlled, Parallel-Group Study of MR-107A-02 for the Treatment of Acute Postoperative Pain Following Herniorrhaphy

• Status: Completed
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 579 (actual)
• Sponsor: Viatris Specialty LLC · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

MR-107A-02 is being studied to investigate its efficacy and safety for treatment of acute pain after herniorrhaphy.

Conditions

• Acute Pain
• Post Operative Pain
• Pain

Interventions

Type	Name	Description
DRUG	MR-107A-02	tablet
DRUG	Tramadol	over-encapsulated tablet
DRUG	Placebo	over-encapsulated tablet and/or tablet
PROCEDURE	Herniorrhaphy	Unilateral open inguinal herniorrhaphy with mesh under general anesthesia

Timeline

• Start date: 2023-12-29
• Primary completion: 2025-01-31
• Completion: 2025-03-12
• First posted: 2024-01-22
• Last updated: 2026-02-10

Locations

18 sites across 1 country: United States

Regulatory

• FDA-regulated drug study